abstract |
Anti-CD19 heavy chain antibodies (e.g., UniAbsTM) are disclosed, along with methods of making such antibodies, compositions, including pharmaceutical compositions, comprising such antibodies, and their use to treat B cell disorders that are characterized by the expression of CD19. |